MedPath

Mechanisms of Muscle Blood Flow Dysregulation and Exercise Intolerance in Chronic Kidney Disease

Not Applicable
Terminated
Conditions
Chronic Kidney Disease
Interventions
Behavioral: Forearm exercise training
Registration Number
NCT02664519
Lead Sponsor
University of Texas Southwestern Medical Center
Brief Summary

Patients with chronic kidney disease (CKD) experience fatigue and exercise intolerance. Increased oxidative stress in CKD may be a contributing factor. The role of impaired muscle blood flow regulation has not been fully explored. The investigators hypothesize that functional sympatholysis is exaggerated in CKD and this is associated with increased oxidative stress. The investigators also hypothesize that exercise training will improve functional sympatholysis and oxidative stress

Detailed Description

Progressive muscle weakness and premature fatigue are characterize the condition of chronic kidney disease (CKD) which can be very debilitating. Mechanisms underlying exercise intolerance in CKD is not completely understood. Previous studies have demonstrated impaired skeletal muscle vasodilation during exercise in CKD patients, which may contribute to exercise intolerance. Normally, there is blunting of sympathetic mediated vasoconstriction in exercising muscle to allow for steady blood supply to exercising muscles. This phenomenon is called functional sympatholysis. Functional sympatholysis is impaired by increases in reactive oxygen specie and may be impaired in CKD.

Experiments will be performed on 2 groups of subjects 1) Normal kidney function (eGFR\>90) 2) Stage 2-3 CKD (eGFR 30-89). VAsoactive medications will be held for 72 hours before study. All participants will attend a baseline study visit, which will include a physical examination, a medical history review, vital sign measurements, and blood collection. Muscle nerve activity and muscle oxygenation will be measured while the subjects perform hand grip exercise at 30% maximum voluntary contraction with and without lower body negative pressure (- 20 mmHg). Muscle blood flow will be measured before and after hand grip exercises. CKD subjects will then be randomized to exercise training (to squeeze a tennis ball repeatedly for at least 30 min/day) or no exercise training for 28 days. Procedures in baseline visit will be repeated followed by cross over to alternate group for 28 days followed by repeat of baseline procedures. Blood flow, muscle oxygenation and muscle nerve activity will be compared between CKD and normal subjects as well as before and after exercise training for CKD subjects.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • Normotensive adults
  • CKD 2-3
Read More
Exclusion Criteria
  • Blood Pressure ≥140/90
  • eGFR >60ml/min/1.73 m2 or eGFR <30ml/min/1.73 m2
  • Any evidence of cardiopulmonary disease, left ventricular hypertrophy or systolic dysfunction by echocardiography.
  • Diabetes mellitus or other systemic illness
  • Pregnancy
  • Any history of substance abuse or current cigarette use
  • Any history of psychiatric illness
  • History of malignancy
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
No exercise training followed by exercise trainingForearm exercise trainingCKD subjects will be randomized to exercise training (to squeeze a tennis ball repeatedly for at least 30 min/day) or no exercise training for 28 days. Procedures in baseline visit will be repeated followed by cross over to alternate group for 28 days followed by repeat of baseline procedures.
Exercise training followed by no exercise trainingForearm exercise trainingCKD subjects will be randomized to exercise training (to squeeze a tennis ball repeatedly for at least 30 min/day) or no exercise training for 28 days. Procedures in baseline visit will be repeated followed by cross over to alternate group for 28 days followed by repeat of baseline procedures.
Primary Outcome Measures
NameTimeMethod
Change in muscle oxygenationAfter 28 days

Tissue oxygenation will be recorded using Near-infrared spectroscopy (NIRS)

Secondary Outcome Measures
NameTimeMethod
Change in Forearm vascular conductance (FVC)After 28 days

Doppler ultrasonography to measure blood flow

Change in plasma isoprostanesAfter 28 days

Plasma isoprostanes will be used as a measure of oxidative stress

Change in muscle sympathetic nerve activity (MSNA)After 28 days

MSNA will be measured using tiny tungsten wire inserted into the common peroneal nerve below fibular head.

Trial Locations

Locations (1)

University of Texas Southwestern Medical Center at Dallas

🇺🇸

Dallas, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath